Invention Grant

PD-1 antibodies
Abstract:
The present invention provides antibodies that bind human programmed cell death 1 (PD-1), and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.
Public/Granted literature
Information query
Patent Agency Ranking
0/0